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cationic, lysine-branched, amphipathic,
helical peptides
Naveen K Kaushik, Jyotsna Sharma and Dinkar Sahal*Abstract
Background: A lack of vaccine and rampant drug resistance demands new anti-malarials.
Methods: In vitro blood stage anti-plasmodial properties of several de novo-designed, chemically synthesized,
cationic, amphipathic, helical, antibiotic peptides were examined against Plasmodium falciparum using SYBR
Green assay. Mechanistic details of anti-plasmodial action were examined by optical/fluorescence microscopy
and FACS analysis.
Results: Unlike the monomeric decapeptides {(Ac-GXRKXHKXWA-NH2) (X = F,ΔF) (Fm, ΔFm IC50 >100 μM)}, the
lysine-branched,dimeric versions showed far greater potency {IC50 (μM) Fd 1.5 , ΔFd 1.39}. The more helical
and proteolytically stable ΔFd was studied for mechanistic details. ΔFq, a K-K2 dendrimer of ΔFm and (ΔFm)2
a linear dimer of ΔFm showed IC50 (μM) of 0.25 and 2.4 respectively. The healthy/infected red cell selectivity
indices were >35 (ΔFd), >20 (ΔFm)2 and 10 (ΔFq). FITC-ΔFd showed rapid and selective accumulation in
parasitized red cells. Overlaying DAPI and FITC florescence suggested that ΔFd binds DNA. Trophozoites and
schizonts incubated with ΔFd (2.5 μM) egressed anomalously and Band-3 immunostaining revealed them not
to be associated with RBC membrane. Prematurely egressed merozoites from peptide-treated cultures were
found to be invasion incompetent.
Conclusion: Good selectivity (>35), good resistance index (1.1) and low cytotoxicity indicate the promise of ΔFd
against malaria.
Keywords: Anomalous egress, Anti-plasmodial peptides, De novo peptide design, Kinetics of peptide uptake,
Peptide binding to DNA, Plasmodium falciparumBackground
The devastating diseases caused by protozoan para-
sites are a major burden of the tropics, and in par-
ticular, Plasmodium falciparum, the causative agent of
falciparum malaria, creates a serious public health prob-
lem in many areas of the densely populated developing
world. The widespread resistance of P. falciparum to
chloroquine (CQ), which has spread from Asia to Africa,
has rendered the drug ineffective against the most danger-
ous Plasmodium strain in many affected regions of the
world. Unfortunately, CQ-resistance is associated with
cross-resistance to other quinoline drugs, such as quinine* Correspondence: dinkar@icgeb.res.in
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reproduction in any medium, provided the orand amodiaquine [1]. Plasmodium falciparum is genetic-
ally diverse and has multiple independent origins of muta-
tions in genes that confer resistance to widely used
anti-malarial drugs [2]. Left with just artemisinin to fight
against malaria, Arata Kochi, Director of the Malaria
Division at the World Health Organization, had felt com-
pelled to say “if we lose artemisinin, we will no longer have
an effective cure for malaria” [3]. However, most recently,
alarming signs of clinical resistance against artemisinin, in
the form of delayed parasite clearance, are being observed
in the border between Cambodia and Thailand [4,5]. The
challenge of designing an effective vaccine along trad-
itional lines against malaria is that many P. falciparum
proteins are highly polymorphic and their functions are
redundant [6]. More than 200 million new malaria casesLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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urgent requirement for new drugs against malaria.
Peptides are an essential component of defence mech-
anism of all life forms and anti-microbial peptides are
evolutionarily ancient biological weapons. Their wide-
spread distribution throughout the living kingdom sug-
gests that anti-microbial peptides may have served a
fundamental role in the successful evolution of complex
multi-cellular organisms [8]. Despite their ancient lineage,
anti-microbial peptides have remained effective defensive
weapons, defeating the general belief that bacteria, fungi
and viruses can and will develop resistance to any conceiv-
able substance. Among other differences, uniquely anionic
charge on bacterial surface is a curious feature that distin-
guishes the prokaryotic bacteria from their eukaryotic
counterparts [9]. Anti-microbial peptides gain selectiv-
ity from their ability to target this previously under-
appreciated ‘microbial Achille’s heel’ [10-12]. Interestingly,
a seminal feature of the malaria parasite-infected red cell
is reflected in an altered asymmetry of lipid composition
in its cell surface membrane. In contrast to the uninfected,
healthy red cell, the malaria-infected red cell shows a
translocation of the anionic phosphatidylserine from the
inner leaflet to the outer leaflet of the bi-layer [13]. As a
result, the FITC-Annexin negative, healthy red cell now
turns to become FITC-Annexin positive [14]. Thus a
Plasmodium-infected red cell seems to mimic the anionic
surface charge that characterizes the bacterial cell surface.
In principle, this is expected to make malaria-infected red
cells become vulnerable to the action of anti-microbial
peptides. Indeed, naturally occurring or modified peptides,
such as dermaseptin [15], oligoacyllysine [16], cyclosporin
A [17], cecropin A [18], NK-2 [14] and meucin [19], have
been found to display in vitro anti-malarial activity. Some
membrane-active, hydrophobic peptides of fungal origin
have also been found to exhibit in vitro anti-malarial ac-
tion [20]. However, many of these naturally occurring pep-
tides suffer from drawbacks such as poor potency, stability
and selectivity [21]. Therefore, in a bid to improve their
performance, efforts are being made to engineer peptides
in diverse ways with the aim of reducing their size, im-
proving their stability against proteases and enhancing
their selectivity [22-24]. The structure activity relation-
ships of a series of de novo-designed, conformationally-
constrained helical, amphipathic, cationic peptides against
bacteria have earlier been reported [25]. In the present
work, the potent anti-plasmodial action of these peptides
against both CQ-sensitive and CQ-resistant strains of P.
falciparum are being reported. The results indicate that a
lysine-branched, dimeric peptide ΔFd, which is highly po-
tent (IC50 1.39 μM) across CQ-sensitive and CQ-resistant
strains {Resistance Index (IC50 CQ resistant strain/ IC50
CQ sensitive strain)1.1} of P. falciparum, fairly selective
against parasitized red blood cells {Selectivity Index (HC50URBC/IC50 P. falciparum) >35) and fairly non toxic to
mammalian HeLa cells (TC50 >25 μM), stalls parasite
growth by causing arrest of ring stage parasite, anomalous
egress of trophozoites and premature egress of schizonts
that fail to produce invasion competent merozoites.
Methods
Peptides
Peptides ΔFm, (ΔFm)2, ΔFd, ΔFq, Fm, Fd, D-Lys- ΔFd,
prochitinase and E30 (Table 1) were synthesized by
Fmoc chemistry-based, manual, solid-phase synthesis.
Didehydrophenylalanine (ΔF) was chosen since it is a
conformationally-constrained amino acid residue with a
proven reputation to confer helical character to peptides.
FITC derivatizations of (ΔFm)2 and ΔFd were done after
linking aminohexanoic acid to the N terminus. Peptides
were purified to >95% homogeneity by RPHPLC and
characterized by mass spectroscopy and circular dichro-
ism as described previously [25]. Chromatographic and
mass spectral characterization is given as follows: RPHPLC
profiles of control peptides prochitinase, E30 and bovine in-
sulin (Additional file 1); ΔFm and ΔFd (Additional file 2)
Electro Spray Mass Spectroscopy (ESMS) profiles of pro-
chitinase, E30 and bovine insulin (Additional file 3); ESMS
profiles of ΔFm and ΔFd (Additional file 4); MALDI of
(ΔFm)2 (Additional file 5), RPHPLC and mass spectral
data for ΔFq (Additional file 6) and ESMS profiles of Fm,
D-Lys- ΔFd and Fd (Additional file 7). Peptides corre-
sponding to prochitinase, E30 (a 30 residues-long peptide
from Hepatitis E virus ORF3) (synthesized and character-
ized in house) and bovine insulin (Sigma) were used
as controls in experiments on ΔFd mediated selective
haemolysis of infected red cells. FITC-Insulin (Sigma)
was used as control in experiments done to study the
uptake of FITC tagged (ΔFm)2 and ΔFd by Plasmodium-
infected RBCs.
In vitro cultivation of Plasmodium falciparum
Chloroquine-sensitive (3D7) and CQ-resistant (Dd2 and
INDO) strains of P. falciparum were maintained in con-
tinuous culture according to the method of Trager and
Jensen [26] with minor modifications. Cultures were main-
tained in fresh group O+ve human erythrocytes suspended
at 4% haematocrit in complete medium {16.2 g/L RPMI
1640 containing 25 mM HEPES, 11.11 mM glucose
(Gibco), 0.2% sodium bicarbonate (Sigma), 0.5% Albumax I
(Gibco), 45 μg/litre hypoxanthine (Sigma) and 50 μg/litre
gentamicin (Gibco)} and incubated at 37°C under a gas
mixture 5% O2, 5% CO2, and 90%N2. Every day, the spent
medium was replaced by fresh complete medium to propa-
gate the culture. For INDO strain in culture medium, albu-
max was replaced by 10% pooled human serum (Innovative
Research) as suggested by MR4 [27]. Parasitaemia was
monitored by microscopic examination of Giemsa-stained
Table 1 In-vitro blood stage antiplasmodial activities, resistance and selectivity indices of peptides against different
strains of P. falciparum
Peptides Peptide Sequence and design IC50 P. falciparum (μM) Resistance index HC50 URBC
μM3D7 Dd2 INDO IC50Dd2/ IC503D7
Fm Ac-GFRKFHKFWA-NH2 >100 >100 - >100
ΔFm Ac-GΔFRKΔFHKΔFWA-NH2 >100 >100 - - >100
ΔFd 1.39 ± 0.1 1.6 ± 0.09 1.5 ± 0.075 1.15 >50 ( >35)*
D-Lys-ΔFd** 1.8 ± 0.07 - - - >50 (> 27)
Fd 1.5 ± 0.08 - - - >50 (>33)
(ΔFm)2 Ac-GΔFRKΔFHKΔFWAAGΔFRKΔFHKΔFWA-NH2 2.4 ± 0.15 2.5 ± 0.13 - 1.04 >50 (>20)
ΔFq 0.25 ±0.02 - - - 2.5 ±0.13 (10)
Prochitinase EEPHKAASAEGKK > 40 - - - > 40




> 40 - - - > 40
Artemisinin 0.015 0.016 0.015 1
Chloroquine 0.04 0.16 0.5 4
* Hemolytic Selectivity index (HC50URBC/ IC50Pf3D7) is shown in parenthesis, **: K
D refers to Lysine of D configuration. Values of standard deviation given as ± are
based on three independent observations.
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obtained by 5% sorbitol treatment [28]. Trophozoites
and schizont-stage parasites were enriched by using
Percoll gradient [29].Drug dilutions
Stock solutions of peptides and CQ were prepared in
water (milli-Q grade) while artemisinin stock solution
was in dimethyl sulphoxide (DMSO). All stocks were
then diluted with culture medium to achieve the
required drug concentrations. The concentration of pep-
tide solution in water was based on A280 [E (M
-1 cm-1)
ΔF (didehydrophenylalanine) 19,000, W (Tryptophan)
5,000)]. Thus E280 were 62,000, 124,000, 124,000 and
248,000 for ΔFm, (ΔFm)2, ΔFd and ΔFq respectively.
The concentration of FITC-peptides was based on A495
[E(M-1 cm-1) FITC 77,000 for (ΔFm)2 with one FITC and
154,000 for ΔFd with two FITC per molecule]. Drugsand peptides solutions were placed in 96-well flat bot-
tom tissue culture grade plates (Corning).Assay for anti-plasmodial activity
For drug screening, SYBR green I based fluorescence
assay was used as described previously by Smilkstein
et al. [30]. Sorbitol synchronized ring stage parasites
(haematocrit: 2%, parasitaemia: 1%, 100 μl) under nor-
mal culture conditions were incubated in the absence or
presence of increasing concentrations of peptides in
water. CQ and artemisinin were used as positive con-
trols. Vehicle control 0.4% DMSO (which was found to
be non-toxic to parasite) was used in case of artemisinin.
After 48 hr of incubation 100 μl of SYBR Green I buffer
[0.2 μl of 10,000 X SYBR Green I (Invitrogen) per ml of
lysis buffer {Tris (20 mM; pH 7.5), EDTA (5 mM),
saponin (0.008%; wt/vol), and Triton X-100 (0.08%;
vol/vol)}] was added to each well, mixed twice gently
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for 1 h. Fluorescence was measured with a Victor fluores-
cence multi-well plate reader (Perkin Elmer) with excita-
tion and emission wavelength centred at 485 and 530 nm,
respectively. Fluorescence counts for CQ (0.1 μM for 3D7,
1 μM for INDO) were subtracted from counts in each
well. The fluorescence counts were plotted against the
drug concentration and IC50 (the 50% inhibitory concen-
tration) was determined by analysis of dose–response
curves. Results of the above mentioned fluorescence-
based assay were validated microscopically by examination
of Giemsa-stained smears of peptide-treated parasite cul-
tures. Statistical significance of relative potencies of pep-
tides was determined by student’sT test.
In vitro stage dependence of action
Stage specificity of action of ΔFd on the parasite’s blood
stage life cycle was determined by microscopic analysis of
the effect of ΔFd on each of the three stages (ring, tropho-
zoite and schizont) of the parasite life cycle. Synchronized
stages were obtained by sorbitol-mediated synchronization
repeated thrice (synchronization 1, medium washed, incu-
bation for 3 hr, 370C, synchronization 2, medium washed
and culture allowed to grow in complete medium for
48 hr. At this stage the culture was synchronized a third
time to obtain highly synchronized ring stage culture).
This culture was grown for 24 hr and 38 hr to obtain
trophozoite and schizont stage cultures respectively. Both
trophozoite and schizont enriched cultures were subjected
to Percoll gradient centrifugation to obtain highly purified
parasites of specific stages. Giemsa-stained smears were
microscopically observed over 2,000 RBCs to obtain dif-
ferential counts.
Cultures (1% parasitaemia, 2% haematocrit) at each of
the above mentioned stages were seeded in 96-well
plates containing different concentrations of ΔFd and
the plates incubated for 12 h (schizont), 24 h (trophozo-
ite) and 48 h (ring) under standard culture condition.
Smears were drawn, Giemsa-stained and analysed micro-
scopically. Stage-specificity of action was assessed by ob-
serving the stage transitions in drug-treated samples
against untreated controls.
Cytotoxic activity of ΔFd on HeLa cells using MTT assay
The cytotoxic effects of ΔFd on mammalian cells was
assessed by functional assay as described [31] using
HeLa cells cultured in RPMI containing 10% fetal bovine
serum, 0.21% sodium bicarbonate (Sigma) and 50 μg/mL
gentamycin (complete medium). Briefly, cells (104 cells/
200 μl/well) were seeded into 96- well flat-bottom tissue
culture plates in complete medium. Peptide solutions
were added after 24 hr of seeding and incubated for
48 hr in a humidified atmosphere at 37°C and 5% CO2.
DMSO (as positive inhibitor) was added at 10%. Twentymicrolitres of a stock solution of MTT (5 mg/mL in 1X
phosphate buffered saline) was added to each well, gen-
tly mixed and incubated for another 4 hr. After spinning
the plate at 1500 rpm for 5 min, supernatant was
removed and 100 μl of DMSO (stop agent) was added.
Formation of formazon was read on a microtiter plate
reader (Versa max tunable multi-well plate reader) at
570 nm. The 50% cytotoxic concentration (TC50) of drug
was determined by analysis of dose–response curves.
Haemolysis assay
Selectivity of haemolysis by peptides for infected ery-
throcytes (PRBC) vs uninfected erythrocytes (URBC)
was examined by incubating the test molecules with
URBCs and PRBCs respectively in phosphate-buffered
saline (PBS). Briefly, fresh RBCs were spin washed (1600
RPM; 5 min) three times in PBS and re-suspended in
PBS at 2% haematocrit. A 100 μl suspension was added
to 96-well plate containing the peptides at different con-
centrations. PBS alone (for baseline values) and 0.4%
Triton X-100 in PBS (for 100% haemolysis) were used as
controls. After incubation at 37°C for 3 hr, the samples
were centrifuged and supernatant was used to determine
the haemolytic activity measured in terms of haemoglo-
bin release as monitored by A415. Triton-treated control
samples were diluted 10-fold before reading absorbance.
Base line value (PBS control, <0.3% of the triton value)
was subtracted from each data point. Percent haemolysis
has been expressed with reference to 100% haemolysis
value assigned to positive control (triton X 100 treated
RBCs). To study haemolytic susceptibility of parasitized
cells, URBCs were replaced with varying percentages
(10% and 20%) of mixed stage parasitized cells. Three
different control peptides (insulin prochitinase and E30,
Table 1) were used to find whether there was specificity
in the selective haemolytic action of ΔFd. Haemolysis
of parasitized erythrocytes was also monitored micro-
scopically by examining the Giemsa-stained smears. Para-
sitaemia of ΔFd treated and untreated cultures were
microscopically counted for ring, trophozoite and schizont
stages respectively. Susceptibility of different stages was
compared with corresponding untreated control cultures.
Fluorescence microscopic imaging
To probe mechanistic details of ΔFd-mediated, premature
parasite egress, P. falciparum 3D7 culture (5% parasit-
aemia, 2% haematocrit) was incubated without (control)
or with ΔFd (12.5 μM) at 37°C for 3 hr in a final vol-
ume of 100 μl made with RPMI (96 μl RPMI + 4 μl
peptide solution).
Smears were processed as indicated: (a) flooded with 2%
BSA/PBS (1 hr, 37°C), (b) washed and flooded (1 hr, 370C)
with monoclonal anti-band 3 antibody produced in mouse
(Sigma) (1: 500 dilution in 1% BSA/PBS), (c) PBS washed
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(Sigma)(1: 500 dilution in 1% BSA/PBS,1 hr, 370C in dark),
(d) PBS washed and flooded with DAPI (4, 6-diamidino-2-
phenylindole) (invitogen) (500 ng/ml, 10 min, 370C). After
a final PBS wash the smears were observed under Nikon
eclipse fluorescence microscope.
For studying peptide localization, P. falciparum cultures
were individually incubated with FITC-ΔFd (2 μM), FITC-
(ΔFm)2 (2 μM) or FITC-Insulin (3 μM) a) alone and b) to-
gether with DAPI in complete medium at 37°C for 30 min
and the cells were spin washed (1,600 RPM, 5 min) twice
with 1 X PBS to reduce background fluorescence. The
cells were smeared on a glass slide, and fluorescence was
visualized by using the respective filter settings for FITC
and DAPI.
For studying the selectivity and route of transport of
ΔFd into the red cell-resident malaria parasite, URBC and
PRBC were incubated with FITC-ΔFd (4 μM) in parallel
sets at 4°C vs at room temperature (25°C) for specified
times and spin washed (1,600 RPM, 2 min) with complete
medium (3 X 200 μl). The cells were smeared on a glass
slide and both bright field images and fluorescence images
(using FITC filter) were captured at 100 X magnification
using Nikon eclipse fluorescence microscope. The soft-
ware Adobe Photoshop was used to overlay the fluores-
cence image on the bright field image.
Kinetics of peptide uptake
Kinetics of FITC-labelled peptide uptake was studied







Figure 1 Multivalent cationic, amphipathic helical peptides are poten
Dose-dependent effects of ΔFm (monomer), [(ΔFm)2 and ΔFd] (dimers) an
Plasmodium falciparum (3D7) culture of malaria parasite. The anti-plasmodi
and (ΔFm)2] and the quadrumer ΔFq. The marginal difference in the comp
suggests that there is predominantly early death. Each data point represen(3 μM) was incubated for indicated time intervals with
synchronized rings (~7% parasitaemia, 2% haematocrit)
and synchronized trophozoites (~20% parasitaemia,
2% haematocrit) stage cultures in a total volume of
100 μl. Cells were spin washed (1 min) with 1 ml
PBS and samples injected into FACS.
Results
Inhibition of Plasmodium falciparum growth by peptides
The anti-plasmodial activities of the de novo-designed,
synthetic peptides ΔFm, Fm, ΔFd, D-Lys-ΔFd, Fd, (ΔFm)2
and ΔFq (Table 1), were determined by quantitative SYBR
Green I based estimation of DNA replication after one
developmental cycle (48 hr) as a measure of growth
(see Figure 1 for growth inhibition profiles of ΔFm,
(ΔFm)2, ΔFd and ΔFq). In contrast to the monomers
ΔFm/Fm (IC50 > 100 μM), the dimers showed potent
{IC50 : (ΔFm)2 2.4 μM, ΔFd 1.39 μM, D-Lys-ΔFd 1.8 μM,
Fd 1.5 μM} dose dependent anti-plasmodial action
against the growth of CQ-sensitive, blood stage parasite
(P. falciparum 3D7) in culture. Interestingly the K-K2
branched tetrameric dendrimer ΔFq with IC50 0.25 μM
turned out to be the most potent anti-plasmodial in
the present series. The progressive increment in anti-
plasmodial potency with valency of the peptides sug-
gests an oligomeric state of the peptide is associated
with potency. The haemolysis-based selectivity indices
for the potent peptides were >35 (ΔFd), >20 (ΔFm)2 ,
>27 (D-Lys-ΔFd), >33 (Fd) and 10 (ΔFq). The favourable
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ts the mean+/− SD of three replicates.
Ring Stage synchronized culture after 48 ha
 Untreated             Fd 1.56 M (IC50)        3.12 M (IC80)  
Trophozoite  stage synchronized culture after 24h 
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Figure 2 Microscopy of anti-plasmodial action of ΔFd on Plasmodium falciparum 3D7. (A) Untreated or ΔFd-treated, ring-stage
synchronized cultures (parasitaemia 1%) were observed after 48 hr. Untreated culture shows high ring-stage parasitaemia, ΔFd IC50 and IC80
treated cultures show low trophozoite-stage and low ring-stage arrested parasitaemia respectively, (B) Untreated or ΔFd-treated trophozoite-stage
synchronized cultures were observed after 24 hr. Untreated culture shows intracellular rings while the ΔFd-treated culture shows anomalously
egressed trophozoites. Note the selectivity in action on parasitized cells with no effect on uninfected cells. (C) Untreated or ΔFd-treated schizont stage
synchronized cultures were observed at 6–12 hr. While schizonts with the characteristic rosette arrangement of merozoites are intracellular at 6 hr in
untreated culture, they have (a) prematurely egressed and (b) lost the rosette arrangement of merozoites in the peptide treated culture (For zoom of
the images, see additional file 10, panel A). At 12 hr while the merozoites in control have invaded fresh red cells to form rings, the merozoites of
peptide treated cultures have failed to invade and form rings (For quantitative account of decrease in invasion events , see additional file 10, panel C).
Kaushik et al. Malaria Journal 2012, 11:256 Page 6 of 15
http://www.malariajournal.com/content/11/1/256
Kaushik et al. Malaria Journal 2012, 11:256 Page 7 of 15
http://www.malariajournal.com/content/11/1/256peptide in greater detail. Further, (ΔFm)2 was studied
since it was interesting to compare a linear dimer with a
branched dimer. The K-K2 dendrimeric quadrumer was
not studied in detail due to its poor haemolytic index. Sev-
eral control peptides (Table 1) including sequences corre-
sponding to prochitinase, E30, and bovine insulin showed
no inhibition up to a concentration of 40 μM. Interestingly,
both (ΔFm)2 and ΔFd retained their anti-plasmodial poten-
cies also against the CQ-resistant Dd2 strain resulting in re-
sistance index values of ~1 (Table 1). The more potent,
branched dimer ΔFd showed IC50 value of 1.5 μM against
the highly CQ-resistant INDO strain of P. falciparum.
These results showed that dimerization potentiates anti-
plasmodial activity by more than 50-fold over the corre-
sponding monomer. The small but significant differ-
ence (student’sT test p: 0.013) between the potencies
of the linear [IC50: (ΔFm)2 2.4 μM] and branched
(IC50: ΔFd 1.39 μM) dimers suggests that the mode
of dimerization may also play a subtle role in modu-
lation of potency. When examined for comparative
potency in 48 hr (one cycle) vs 96 hr (two cycles)
assays, only marginal increments in potency [1.5 fold
(ΔFm)2, and 1.1 fold ΔFd] were observed at 96 hr
(Figure 1).Figure 3 Histogram showing results of MTT assay measuring
viability of HeLa cells incubated with ΔFd at different
concentrations. Data shows mean and standard deviation of three
independent observations.Ring vs trophozoite: selectivity in the action of ΔFd
In order to find whether there was ring vs trophozoite se-
lectivity in the action of ΔFd, microscopic evaluation of its
action was studied against parasitized red cells synchro-
nized at ring (Figure 2A) and trophozoite (Figure 2B)
stages respectively. When the ring stage parasite culture
was treated with IC50 dose of ΔFd, it was observed
(Figure 2A) that, after 48 hr of culture, the rings had pro-
gressed only up to the trophozoite stage suggesting bio-
chemical arrest and the resulting interception of the
progression to the schizont stage. Further at IC80, it was
observed that the rings did not mature even to the tropho-
zoite stage and the arrest of the parasite cycle was at
the ring stage. Since ΔFd at its IC50 caused arrest at
trophozoite stage (Figure 2A), the effect of ΔFd at its
IC70 (2.5 μM) was tested on cultures synchronized at
trophozoite stage. It was interesting to see (Figure 2B) that
the peptide caused anomalous egress of trophozoites.
Even as 95% of trophozoites were found to be extra-
cellular (Additional file 8); this phenomenon was not
a consequence of non-specific haemolysis since uninfected
red cells were not affected (Figure 2B). Thus it appears
that at ~ IC80 rings are metabolically arrested and the
RBCs harbouring them are not lysed while such doses
cause selective lysis of parasitized RBCs that harbour tro-
phozoites. The observation of MSP3 staining in~ 40% of
the anomalously egressed trophozoites (Additional file 9)
is worth noting.ΔFd is fairly non toxic to mammalian HeLa cells
Toxicity of ΔFd to mammalian cells was examined by
MTT assay. HeLa cells incubated with varying concen-
trations (2.5-25 μM) of ΔFd (Figure 3) did not show any
toxicity. This suggests that the therapeutic index (TC50
Mammalian cells/IC50 P.falciparum) of this peptide
(>16) is promising.
ΔFd causes premature egress of undifferentiated Schizonts
While it is unnatural for trophozoites to egress, the egress
of schizonts is a natural process that leads to increased
parasitemia. It was therefore interesting to find the effect
of ΔFd on egress of schizonts. As shown (Figure 2C), the
peptide treated cultures showed premature egress at 6 h
at a time when the schizonts in the control culture were
intracellular. A close look at the schizonts of the control
and the peptide treated cultures (see Additional file 10,
panel A) revealed that (a) The characteristic symmetric
rosette arrangement of merozoites seen in control at 6 hr
and 9 hr is absent in the prematurely egressed schizonts
of the peptide treated culture and (b) the well differen-
tiated merozoites of the control are invasion competent
which enables them to form new rings while the mero-
zoites of the peptide-treated culture are invasion disabled
resulting in no new infections of red blood cells. Interest-
ingly merozoites from both the control and peptide trea-
ted schizonts were found to be MSP3+ (Additional file 9).
Selective haemolytic effect of ΔFd
The anomalous egress of trophozoites via haemolysis
motivated an examination of the selectivity in the action
of ΔFd against parasitized (PRBC) vs uninfected red cells
(URBC) over a range of peptide concentrations. As
shown (Figure 4A), while the URBCs showed consider-
able resistance to lysis, the PRBCs showed increasing
lysis both with increasing concentration of peptide and
also with increasing parasitaemia. It may be noted that










































Figure 4 ΔFd causes selective haemolysis of parasitized red
cells leading to anomalous egress of trophozoites. (A) Samples
of mixed stage parasite culture at different parasitaemia (P)
(% figures on respective curves) were incubated (3 hr) with the
indicated concentrations of peptide and percentage haemolysis
estimated by A415. Control peptide (insulin) with infected red cells
(10% trophozoite-stage parasitaemia, solid line); ΔFd with URBC,
(dashed line); ΔFd with 10% parasitaemia (rings 3%, trophozoites 7%,
dashed dotted line); and ΔFd with 20% parasitaemia (rings 5%,
trophozoites 15%, dotted line). Two other control peptides
(prochitinase and E30) behaved like insulin (data not shown).
(B) Shows microscopic analysis of the selective sensitivity of
trophozoites (, anomalously egressed) vs rings (*, intracellular) at
12 μM ΔFd, (C) shows dose-dependent selective effect of ΔFd on
anomalous egress of trophozoites but not rings, monitored
microscopically after incubation (3 hr). Data shown were obtained
after counting 2,000 erythrocytes.
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mixed cultures shown in Figure 4A, the percentage
haemolysis values of 7% and 16% correspond to percent-
age trophozoite populations of ~ 7% and 15%, respect-
ively. Further microscopic evaluation of mixed parasite
cultures treated with ΔFd (12 μM) revealed (Figure 4B)
that only the trophozoites and not the rings were
observed to be extracellular. In order to find if the
observed lysis of infected cells was specific to ΔFd or
would any peptide in general cause similar lysis,
three control peptides (insulin, E30 and prochitinase)
(Figure 4A) were tested and found not to show any haem-
olysis up to a concentration of 40 μM. Microscopic exam-
ination of ~ 2,000 cells from infected red cell cultures
revealed a peptide concentration dependent inverse rela-
tion between intracellular vs extracellular trophozoites
(Figure 4C). Also evident from this figure is the stability of
ring-infected cells up to 12 μM of ΔFd.
Anomalously egressed trophozoites are not surrounded
by host cell membrane
Immunostaining with band 3 antibody was done in order
to find if the trophozoites egressed in response to ΔFd
were free or packaged in host cell membrane. As shown
in Figure 5, while the untreated culture showed the DAPIFigure 5 ΔFd-mediated parasite egressed from red blood cells
are not coated with host cell membrane. Bright field optical
images (top panel) show haemozoin crystals that are intracellular in
control and appear to be extracellular in ΔFd (12.5 μM)-treated
sample. Panel 2 shows DAPI stained nuclei of the malaria parasite.
Panel 3 (immunostaining with band 3 antibody) indicates that band
3 (red) was seen in all cells. Panel 4 (overlay of DAPI and band 3)
indicates that the parasites (staining blue) in control panel are
intracellular and flanked by band 3 stain. But the ΔFd-treated
parasites, which egressed anomalously, are extracellular and not
flanked by band 3.
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staining (red), the egressed extracellular trophozoites in
the ΔFd-treated culture (12.5 μM) had no band 3 stainingA
B
C
Figure 6 Cellular localization of FITC-labelled peptides in Plasmodium
incubated with parasitized culture (30 min, 37°C). Fluorescence image over
parasitized RBCs. Arrow heads:red (trophozoites showing haemozoin), blue
(ΔFm)2 but not FITC-insulin are internalized by PRBC. The overlay of FITC fl
bind to DNA of the parasite. (C)Transport of FITC-ΔFd (4 μM) from RBC sur
surface. The slow entry of FITC-ΔFd into PRBC at 4°C becomes fast at 25°C.around them. This observation suggests that egress does
not involve host cell membrane and is likely to be
mediated via lysis of the host cell.falciparum-infected red blood cells. (A) FITC-ΔFd (3 μM) was
laid on optical image shows that FITC-ΔFd exhibits selective entry into
(likely to be ring stages with low fluorescence). (B) FITC-ΔFd and FITC-
uorescence (green) with DAPI (blue) suggests that these two peptides
face to parasite: ΔFd has selective affinity for infected RBC (PRBC)
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Plasmodium-infected RBCs
To gain a better understanding of the anti-plasmodial
action of the two dimeric peptides, localization of
peptides was studied using fluorophore-labelled pep-
tides. Fluorescence microscopy with FITC-labelled ΔFd
showed that this peptide was selective in targeting the
parasite inside the infected RBC (Figure 6A). Co-
localization of FITC florescence (green) with DAPI flor-
escence (blue) (Figure 6B) indicated that the two pep-
tides bind to the DNA of the malaria parasite. In order
to check whether entry of the two dimers was specific or
would any other peptide also enter parasitized cells,
FITC-labelled insulin was examined for uptake by the
parasitized cells. Fluorescence microscopy revealed that
there was no accumulation of FITC-insulin in parasitized
cells suggesting specificity in uptake and anti-plasmodial
action of the two dimeric peptides. Since no fluorescence
was observed on the red cell surface even as there was
intense fluorescence intracellularly, it was surmised that
the uptake of the peptide may be faster than the time
(30 min) given for the experiment. In order to capture
early events in transfer of the peptide from the RBC sur-
face to the parasite, a comparative uptake study at 4°C
vs at 25°C was performed. As shown (Figure 6C), while
the URBC showed no staining, the PRBC at 4°C showed
predominantly surface staining with a modicum of intra-
cellular staining. However PRBC at 25°C showed a tran-
sition from surface to intracellular staining at 10 min
which became completely intracellular at 30 min. ThusFigure 7 Kinetics of ΔFd entry into parasitized red blood cells (synchr
(~20% parasitaemia). Uptake of fluorescently tagged FITC-ΔFd (2.5 μM) w
peptide uptake profiles obtained with rings and trophozoites, respectively.
Figures against percentage gated indicate the number of cells stained abo
in the number of fluorescent signals with time, and (b) faster uptake by troit appears that parasite-infected red blood cells are well
geared for rapid uptake of this peptide.
Uptake kinetics of ΔFd
In order to assess the kinetics of uptake of the fluores-
cently tagged peptide into the infected red cells, a time-
dependent analysis of the phenomenon was studied by
FACS. Monitoring the uptake in ring-synchronized cul-
tures (Figure 7) revealed a low uptake (1.97%) at the first
minute rising to ~3% at 20 min. In contrast to rings, the
analogous peptide uptake by trophozoites was found to
be fast at the very first minute (7.6%) with further sub-
stantial rise to 22% at 20 min.
Discussion
The success of antibiotics is based upon the characteris-
tic molecular targets that distinguish the prokaryotic
bacteria from the nucleated eukaryotic cells [32,33]. Cat-
ionic, amphipathic helical, antibiotic peptides also seem
to gain specificity by exploiting the fact that bacteria
have a preponderance of anionic lipids, such as phospha-
tidylglycerol and bis(phosphatidyl)glycerol (cardiolipin),
conferring a negative charge on their surface. In con-
trast, their eukaryotic counterparts have a high density
of zwitterionic lipids such as phosphatidylcholine and
phosphatidylethanolamine, enabling their surfaces to be
largely neutral [34,35]. A well-studied and yet curious
feature of the human red blood cell is the transition
from FITC-Annexin negative to FITC-Annexin positive
status upon infection with the malaria parasite [14]. It isonized rings (~7% parasitaemia) and synchronized trophozoites
as monitored by flow cytometry at 25°C. Panels A and B depict the
Zero minute profiles correspond to samples not treated with peptide.
ve the threshold line. Note (a) the fast uptake and progressive increase
phozoites compared to ring-stage parasitized cells.
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translocation of the anionic phosphatidylserine from the
inner to the outer leaflet of the lipid bilayer. Thus infec-
tion with Plasmodium confers an anionic character to
the red blood cell giving it a shade of semblance to a
bacterial membrane. Focusing on the altered membrane
asymmetry seen in the infected red cell, the interesting
anti-plasmodial properties of several de novo-designed,
cationic, amphipathic, helical, bonafide membrane-active
anti-bacterial peptides have been examined in the
present studies.
The first observation of the comparative anti-plasmodial
potencies of two monomeric (ΔFm, Fm) and four di-
meric peptides {ΔFd, Fd, D-Lys-ΔFd, (ΔFm)2}(Table 1)
indicated that the dimers (IC50 1.39- 2.4 μM) were
about two orders of magnitude more potent than the
monomers (IC50 >100 μM). Among the dimeric pep-
tides {ΔFd: IC50 1.39 μM, D-Lys-ΔFd: IC50 1.8 μM,
(ΔFm)2: IC50 2.4 μM, Fd: IC50 1.5 μM}, the lysine-
branched ΔFd was chosen for detailed mechanistic stud-
ies since it had favourable features of anti-plasmodial
potency and selectivity index (>35). Interestingly, in
going from this bivalent-branched dimer ΔFd to the tetra-
valent K-K2-branched quadrumer ΔFq (IC50: 0.25 μM), a
further six-fold potentiation was observed. However, as
shown in Table 1, this potentiation was associated with a
decline in selectivity index from >35 (ΔFd) to 10 (ΔFq).
Nevertheless, the trend of increasing anti-plasmodial po-
tency with increasing valency (monomer to dimer to
quadrumer) of the peptide suggests that oligomerization
on cell surfaces may play an important role in the anti-
plasmodial action of these cationic, amphipathic peptides.
It is important to note that crystal structures of several
ΔF-containing peptides have revealed the propensity of
this planar aromatic residue to engage in long-range, mul-
ticentred interactions (N-H. . .O, C-H. . .O, C-H. . .π, and
N-H. . .π) that can stabilize oligomeric states like the ΔF
zipper [36] in the absence of linker, or the helical hairpins
in the presence of appropriate linker [37,38]. The coming
together of optimal values of anti-plasmodial potency and
selectivity indices (haemolytic selectivity index >35 and
mammalian cell cytotoxicity index >16) in the lysine-
branched dimeric ΔFd became the motivation to unravel
mechanistic details of the anti-plasmodial action of this
peptide. (ΔFm)2, the corresponding linear dimer, was also
studied in some experiments to explore if the mode of
dimerization may influence the anti-plasmodial actions of
these two dimeric peptides.
The essentiality of apicoplast, an organelle of cyano-
bacterial origin in the malaria parasite, is well known to
make the parasite vulnerable to antibiotics,such as tetra-
cycline, clindamycin and thiostrepton [39,40], which are
known to cause delayed death in malaria parasite. This
phenomenon, caused by targeting of the apicoplast orthe mitochondrion, is characterized by a significantly
lower IC50 post second cycle (at 96 hr) vs the first cycle
(at 48 hr) [41]. In order to find if the anti-plasmodial
peptides under study may be targeting organelles such
as the apicoplast of the malaria parasite, comparative
anti-plasmodial potencies against P. falciparum 3D7
were determined at both 48 hr and 96 hr. Since the data
(Figure 1) did not show a significant reduction of IC50 at
96 hr, the possibility that ΔFd and (ΔFm)2 may cause early
death by influencing several other targets besides the api-
coplast and the mitochondria cannot be ruled out.
In trying to gain a better understanding of the prob-
able mechanisms that confer the malaria parasite growth
inhibitory properties on the dimeric peptide ΔFd, the
peptide-treated samples were examined by microscopy.
As shown (Figure 2A), in comparison to the untreated con-
trol (high ring-stage parasitaemia), while the IC50-treated
ring stage synchronized culture was found to have the ini-
tial low parasitaemia (1%) and growth arrest at trophozoite
stage, the IC80 treated sample was found to have the intial
parasitaemia (1%) with the few parasitized cells showing
arrested, probably dead pyknotic ring forms. Interest-
ingly, the microscopic examination of the ΔFd-treated,
trophozoite-enriched culture (Figure 2B) showed the pres-
ence of extra erythrocytic Giemsa-positive trophozoites
alongside uninfected red blood cells. Indeed manual
counting of a large number of fields (Additional file 8)
indicated that over 95% of the trophozoites were in fact
extracellular. The presence of extracellular trophozoites in
the midst of intact uninfected red blood cells was suggest-
ive of the selective haemolytic action of ΔFd on parasitized
cells causing anomalous release of trophozoites following
24-hr incubation.
The transition of ring stage to trophozoite stage in
presence of ΔFd at its IC50, indicates that while this low
dose is sufficient to arrest trophozoites, it is clearly not
sufficient to halt the ring from moving to the trophozo-
ite stage (Figure 2A). This heightened sensitivity of
trophozoite-stage cultures over ring-stage cultures may
be related to the enormous red cell reorganizational
changes associated with a fast feeding, actively metabol-
izing and replicating life style of trophozoite in compari-
son with the more sedentary ring stage. The selective
lysis of trophozoite-bearing cells (Figure 4B) also sug-
gests that such remodelling of the trophozoite harbour-
ing red cell membrane [42] may be rendering it more
vulnerable to the action of membrane active peptides
like the ΔFd. The greater vulnerability of trophozoite
bearing over ring-bearing red cells is evident also from
the fact that peptide-mediated haemolysis is directly pro-
portional to the percentage trophozoites in mixed stage
culture samples (Figure 4A).
Trophozoite egress, induced by the peptide, is not nat-
ural to the life cycle of the malaria parasite. Hence, it
Figure 8 Model of antiplasmodial action of ΔFd. ΔFd causes
growth arrest of rings, anomalous egress of trophozoites and
premature egress of schizonts. Its IC80 (3.12 μM) and IC50
(1.56 μM) cause arrest of rings and trophozoites respectively and its
IC70 (2.5 μM) causes the anomalous egress of trophozoites and
premature egress of schizonts. In both cases the parasite fails to
proliferate since egressed trophozoites cannot differentiate into
schizonts and the premature, undifferentiated egressed schizonts
seem to release merozoites that are invasion incompetent. The
peptide shows good selectivity against parasitized RBCs since 16X
IC80 fails to lyse healthy RBCs.
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involved in the process. To address this issue, the
peptide-treated sample was exposed to immunostaining
with band 3 antibody. As shown (Figure 5), the egressed
trophozoites were not flanked by band 3 staining sug-
gesting that the process is more likely to be caused by
lysis of the infected host cell. A closer examination of
the phenomenon of ΔFd-mediated anomalous egress of
trophozoites revealed that in trophozoite-ring mixed cul-
ture exposed to FITC-ΔFd at low concentrations (2 μM)
and short time (30 min) (Figure 5A), the peptide seems
to enter and attack the parasite from within without
causing immediate lysis of the infected red cell. However
when trophozoite-stage culture was exposed to ΔFd for
longer times (24 hr), at similar low concentrations
(2 μM), this peptide seemed to cause selective lysis of
parasitized cells leading to anomalous egress of tropho-
zoites (Figure 2B). Further, at higher concentrations
(12.0 μM) this peptide caused selective lysis of red cells
harbouring trophozoites within 3 hr (Figure 4B).
Unlike trophozoites, schizonts have an intrinsic pro-
gram of egress that causes the release of numerous mer-
ozoites leading to infection of fresh red cells causing
amplification of infection and increasing the severity of
disease. Hence it was interesting to find if ΔFd may per-
turb the programmed process of egress in schizonts. As
shown (Figure 2C and Additional file 10), this peptide
caused premature egress of schizonts. As a consequence,
the egressed schizonts which showed lumps of amplified
DNA did not exhibit the characteristic symmetrically
organized rosette appearance of merozoites seen in the
untreated control schizont. Further the merozoites from
the peptide treated culture showed a significantly low in-
vasion efficiency in comparison to the control mero-
zoites (Additional file 10). Figure 8 summarizes the
versatility of ΔFd to target each stage of the life cycle of
P. falciparum in characteristic and decisive ways with
good selectivity.
Malaria parasites go to extraordinary means to modify
RBC membrane, which separates them from the external
world. These modifications include a marked increase in
erythrocyte membrane fluidity [43-46], alterations in
host cell lipid fatty acid composition [47,48] and
phospholipid-transbilayer distribution [49], enhancement
of the rate of lipid transbilayer movement [50,51] and
increased permeability through newly formed pores on
the erythrocyte membranes [52,53]. As a part of these
major re-organizational events, the malaria-infected red
cell is well known to exhibit a translocation of the an-
ionic phosphatidylserine from the inner leaflet to the
outer leaflet of the bi-layer [13,54]. This more negative
cell surface may provide the force for the fast and spe-
cific uptake of cationic peptides by the malaria-infected
red cell. Previous studies have indicated that high levelsof cellular uptake can be achieved through the inclusion
of cationic residues into arginine-based peptide oligo-
mers [55]. The positive molecular charge facilitates
charge-driven uptake through the plasma membrane,
which exhibits a potential gradient that can electrophor-
ese cationic species from the extracellular space into the
cell [56,57]. Interestingly, a recent study has demon-
strated that membrane asymmetry can be altered and
maintained in the altered state by externally added poly-
L-lysine [58]. The combined microscopic (Figure 6) and
FACS analysis (Figure 7) suggests that ΔFd enters the
infected cells and stains rings and trophozoites within a
few minutes. Thus it is quite likely that ΔFd and (ΔFm)2,
the two cationic dimeric peptides studied here, in close
resemblance to poly-L-lysine, may first home on those
infected red blood cells that show slightly more anionic
character as a result of alterations in membrane asym-
metry and binding of these cationic peptides could
further enhance and maintain this anionic character
facilitating the stronger binding and faster internalization
of peptides into the infected cells.
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brane, the parasitophorous vacuole membrane, the para-
site plasma membrane and also the parasite nuclear
membrane to reach the nucleus of the parasite
(Figure 6B), indicates its resemblance to cell-penetrating
peptides which are known to have a lipophilic-cationic
character. Even as the peptide was apparently targeting
the DNA of the parasite, the absence of FITC-ΔFd on
the host red cell membrane or all the subsequent mem-
branes mentioned above was puzzling. It was surmised
that these localizations may have been missed due to the
rapidity of the process of peptide uptake. In order to
capture some stages preceding the intranuclear entry of
the peptide, the peptide-staining experiment was per-
formed as a function of both time and temperature. As
shown (Figure 6C), the images captured at 4°C (30 min)
indeed showed predominant staining on the host cell
surface. In contrast, the images corresponding to 25°C
(10 min) and 25°C (30 min) showed progressively
greater staining of the intracellular parasite nuclear ma-
terial. These results suggest that this peptide crosses
several membranes of the infected red cells before
entering the nucleus.
The most probable reasons for the significantly
enhanced potency of the dimers ΔFd/Fd over the mono-
mers ΔFm/Fm include increased membrane binding
and permeabilization, enhanced binding affinity for
DNA and proteins and enhanced biochemical stability
against degradation by proteases. These properties ori-
ginating from increased avidity and affinity of inter-
actions unique to dimeric peptides and absent in
monomeric peptides have been described previously
[25]. In studies on the antibiotic action of these peptides it
has previously been observed that the requirements of heli-
city for potent antibiotic action are much higher for the
gram positive Staphylococcus.aureus than is the case with
the Gram-negative Escherichia coli. In contrast, as shown
in the present study, all dimers {(ΔFd, Fd, D-Lys-ΔFd,
(ΔFm)2} are nearly equipotent against P. falciparum
(Table 1). This suggests that different conformational and
topological properties of peptides may be important for
their activity against different organisms.
Some important features of these peptides as drugs
against malaria include their favourable resistance indices
(Table 1) that allow them to rapidly kill both drug-sensitive
and drug-resistant strains of malaria parasite with equal po-
tencies, their amphipathic nature that gives them drug-like
character, and their ability to permeabilize and penetrate
biological membranes, which allows them to attack target
cells both from the surface as well as intracellularly. In
addition, the presence of the conformationally constrained,
non-protein, amino acid didehydrophenylalanine in both
ΔFd and (ΔFm)2 provides considerable protection against
proteolytic degradation [25]. Even as these two dimericpeptides offer similar profiles of anti-plasmodial actions, a
judicious choice for further improvisation should be the
branched dimer ΔFd over the linear dimer (ΔFm)2 since
(a) the former is little more potent against P. falciparum,
(b) the branched dimer is more stable against proteases
[25], and (c) the branched dimer has better economics of
production since the time it takes to synthesize a
branched dimer is half as much as the time it takes to
assemble a linear dimer.Conclusion
This study reports the anti-plasmodial action of ΔFd, a
de novo-designed, cationic, lysine-branched amphipathic,
helical peptide. In vitro assays suggest good selectivity
(>35), good resistance index (1.1) and low mamamalian
cell cytotoxicity, as a promise of ΔFd against malaria.
The strategy adopted by ΔFd to inhibit the growth of
malaria parasite appears to be broadly two-fold: (a) in-
volving growth arrest without causing lysis of red cell
(at IC50-IC100), and (b) anomalous egress of tropho-
zoites and premature egress of undifferentiated schi-
zonts leading to death of the parasite (at > IC100).
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